{"id":"W3032504166","doi":"10.1200/jco.2020.38.15_suppl.5034","title":"First-line pembrolizumab (pembro) monotherapy in advanced non-clear cell renal cell carcinoma (nccRCC): Updated follow-up for KEYNOTE-427 cohort B.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre; Université Laval","funders":"","keywords":"Medicine; Cohort; Pembrolizumab; Internal medicine; Renal cell carcinoma; Urology; Oncology; Surgery; Gastroenterology; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002430973,0.0005888534,0.0006119089,0.0008715952,0.0006994678,0.0009041568,0.0007127047,0.0005516562,0.002887481],"category_scores_gemma":[0.001789442,0.0003056239,0.0007830634,0.001057945,0.0001438025,0.0006677292,0.0006095373,0.0009293181,0.000999834],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009211971,"about_ca_system_score_gemma":0.001594814,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0116426,"about_ca_topic_score_gemma":0.01554232,"domain_scores_codex":[0.9993162,0.0001647111,0.00007416222,0.00014628,0.000202151,0.00009648493],"domain_scores_gemma":[0.9979727,0.000208768,0.000679375,0.0003243914,0.0003827975,0.0004318687],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.05883269,0.003256082,0.7239835,0.001079035,0.003851715,0.0009361391,0.000431063,0.001873842,0.01208952,0.0004692108,0.06812268,0.1250745],"study_design_scores_gemma":[0.00981389,0.009703407,0.9264392,0.0002264119,0.001894115,0.001062269,0.0001717818,0.001238414,0.002139786,0.0002303196,0.04702104,0.00005947661],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8707116,0.003351868,0.002068961,0.0004806909,0.0001395036,0.002197628,0.1152625,0.00013144,0.005655922],"genre_scores_gemma":[0.7258949,0.00188545,0.00326897,0.001185406,0.0001796728,0.00231614,0.2580076,0.00007099712,0.007190889],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0116426,"threshold_uncertainty_score":0.02314967,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07859138688941952,"score_gpt":0.3847436182841341,"score_spread":0.3061522313947145,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}